<DOC>
	<DOCNO>NCT02967757</DOCNO>
	<brief_summary>This study conduct Europe . The aim study investigate usage liraglutide weight management clinical practice .</brief_summary>
	<brief_title>In-market Utilisation Liraglutide Used Weight Management Europe</brief_title>
	<detailed_description />
	<mesh_term>Nutrition Disorders</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Initiation liraglutide 3.0 mg / liraglutide 1.2 mg/1.8 mg ( initiation define prescription brand within previous 12 month ) Informed consent obtain studyrelated activity . Studyrelated activity procedure carry part study , include activity determine suitability study Patients physicians previously participate interventional study liraglutide 3.0 mg / liraglutide 1.2 mg/1.8 mg eligible participate study For full study , sit patient include pilot exclude</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>